Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics, announced that Derek Hicks was appointed CEO. With more than 25 years of leadership in the pharmaceutical and biotech sectors, Derek brings a strong track record of transformative business devel…
Michael Friede, Chief Executive Officer Brenntag Specialties and member of the Board of Management of Brenntag SE, the global market leader in chemicals and ingredients distribution, has informed the Supervisory Board of Brenntag SE that he will not extend his contract which ends on March 31, 2026. He will leave the c…
Emerald Clinical Trials, a leading global clinical research organization, announced a leadership transition. Mary Gunn has stepped down effective immediately. The Board has appointed Glenn Kerkhof, a long-standing Board member and experienced CRO executive, as Interim CEO. The Board has commenced a formal search for …
Hansa Biopharma AB, announced three leadership appointments. Brian Gorman joins Hansa as Chief Legal Officer and Corporate Secretary, effective August 4; Sandra Frithiof has been appointed Chief Human Resources Officer (CHRO), effective August 4; and Kerstin Falck Lagercrantz will join the company September 1, as Vice…
Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, announced that Geoffrey M. Glass has been appointed Chief Executive Officer (CEO), effective immediately. Mr. Glass has served as Chairman of the Board since 2022. Mr. Glass brings 30 years of experience in the life sciences…
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it has named Emmanuel Ligner, President and Chief Executive Officer, effective August 18, 2025. Mr. Ligner succeeds Michael Stubblefield, who will, as…
Jazz Pharmaceuticals plc announced that the Jazz Board of Directors has unanimously selected Renee Gala, Jazz's President and Chief Operating Officer, as the President and Chief Executive Officer, effective August 11, 2025, when she will also join the Board. She will succeed co-founder, Chairperson and CEO Bruce Cozad…
HiLabs, a leading AI company solving persistent data challenges for U.S. healthcare payers, announced the appointment of Robert L. Renzi as Chief Growth Officer. With over three decades of leadership experience in healthcare technology, payer solutions, and strategic growth, Rob will lead HiLabs' go-to-market strategy…
Tellihealth, a category leader in Remote Patient Monitoring (RPM) and Chronic Care Management (CCM), has strengthened its leadership team with three key executive hires—positioning the company for its next phase of rapid, people-first growth. Joining Tellihealth are: Jill Langenfeld, Chief Operating Officer (COO)L…
BD, a leading global medical technology company, announced that, effective 2 July 2025, Bilal Muhsin has been named executive vice president and will become the president of BD's future Connected Care segment, as part of the company's previously announced plans to update its structure as it advances its New BD strateg…
Page 12 of 16